Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
7,32 GBX | +16,01% | +15,82% | -73,86% |
18/06 | Inkomsten Oxford BioDynamics 49% hoger in eerste helft door stijging testverkoop | AN |
18/06 | Earnings Flash (OBD.L) OXFORD BIODYNAMICS rapporteert omzet voor H1 GBP327.000 | MT |
Vakgebied
Aantal werknemers: 53
Verkoop per activiteit
GBP in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Biomarker Research and Development
62,0
%
| 0 | 100,0 % | 0 | 62,0 % | +105,19% |
Proprietary Products
38,0
%
| - | - | 0 | 38,0 % | - |
Verkoop per regio
GBP in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
76,1
%
| 0 | 69,5 % | 0 | 76,1 % | +262,62% |
Rest of World
23,9
%
| 0 | 30,5 % | 0 | 23,9 % | +159,57% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 62 | 23-04-07 | |
Jon Burrows
CEO | Chief Executive Officer | - | 23-03-20 |
Paul Stockdale
DFI | Director of Finance/CFO | - | 15-09-17 |
Thomas Guiel
COO | Chief Operating Officer | - | - |
Bipin Patel
LAW | General Counsel | - | 01-01-20 |
Bartu Ahiska
PRN | Corporate Officer/Principal | - | 13-06-19 |
Ewan Hunter
PRN | Corporate Officer/Principal | - | 01-01-12 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Diggle
BRD | Director/Board Member | 60 | 04-10-16 |
David Holbrook
BRD | Director/Board Member | 63 | 05-04-19 |
Jon Burrows
CEO | Chief Executive Officer | - | 23-03-20 |
Paul Stockdale
DFI | Director of Finance/CFO | - | 15-09-17 |
Founder | 62 | 23-04-07 | |
Chairman | 65 | 14-12-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 311 855 650 | 263 687 202 ( 84,55 %) | 0 | 84,55 % |
Bedrijfsgegevens
Oxford BioDynamics Plc
3140 Rowan Place John Smith Drive
OX4 2WB, Oxford
+44 1865 518 910
http://www.oxfordbiodynamics.comSector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-73,86% | 16,2 mln. | |
+38,36% | 52,5 mld. | |
+36,73% | 39,31 mld. | |
-8,63% | 39,01 mld. | |
+25,46% | 28,2 mld. | |
-11,17% | 26,57 mld. | |
+11,44% | 26,2 mld. | |
+45,09% | 14,15 mld. | |
+32,93% | 12,62 mld. | |
-5,30% | 11,74 mld. |